Rituximab  |
|
10R024 Mabthera Inj. 500 mg/50 ml/Vial 現行藥物外觀
中文名:莫須瘤
廠牌:羅氏
|
|
| Product
name |
|
| Dosage
form |
| 10R024 Inj. 500 mg/50 ml/Vial |
|
| Indications |
| Non-Hodgkin's Lymphoma:
Single therapy
|
|
| Administration
& Dosage |
| IV infusion,
Non-Hodgkin's Lymphoma:
Single therapy
Initial 375 mg/m2 once wkly for 4 or 8 doses. Retreatment therapy, 375 mg/m2 once wkly for 4 doses (on days 1, 8, 15, and 22). Currently there are limited data concerning more than 2 courses.
|
|
| Contraindication |
| hypersensitivity to rituximab products.. |
|
| Precaution |
|
| Adverse
reaction |
| M: Anemia; hyperglycemia; hypertension; infection; infusion-related reaction; pruritus; rhinitis; urticaria; leukopenia; lymphopenia; peripheral edema; sinusitis; thrombocytopenia; anxiety; arthralgia; asthenia; back pain; diarrhea; dizziness; increased cough; myalgia; night sweats; pain; rash; throat irritation
L: Arthritis; conjunctivitis; depression; mucocutaneous reactions; severe skin reaction; lichenoid dermatitis; vesiculobullous dermatitis; neuritis; neuropathy paresthesia; tumor lysis syndrome resulting in acute renal failure; agitation; anorexia; change in taste; dyspepsia; hyperkinesias; hypertonia; hypesthesia or paresthesia; injection site pain; insomnia; lacrimation disorder; loss of appetite; malaise; nervousness; somnolence; vertigo; weight decrease; angina; cardiac arrhythmias
|
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
|
